Sanofi (SNYNF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Paris, France. The current CEO is Olivier Charmeil.
SNYNF has IPO date of 2008-04-09, 82,878 full-time employees, listed on the Other OTC, a market capitalization of $113.46B.
Sanofi is a multinational pharmaceutical and healthcare company headquartered in Paris, France, engaged in the research, development, manufacture, and marketing of therapeutic solutions globally. The company operates through three core segments: Pharmaceuticals, Vaccines, and Consumer Healthcare, offering a diverse portfolio that includes specialty care products for multiple sclerosis, oncology, rare diseases, immunology, and diabetes; a comprehensive range of vaccines for pediatric and adult populations; and consumer health products spanning allergy relief, pain management, wellness, and dermatological care. With significant operations across the United States, Europe, and international markets, Sanofi collaborates with leading institutions and companies, including GlaxoSmithKline on COVID-19 vaccine development and Stanford University on immunology research, to advance its pipeline of innovative therapeutic solutions.
